Oxford vaccine will protect 95% of patients, should be effective against new variant: AstraZeneca CEO - News Summed Up

Oxford vaccine will protect 95% of patients, should be effective against new variant: AstraZeneca CEO


Oxford University and AstraZeneca's coronavirus vaccine will protect "95% of patients" who get it, Pascal Soriot said. AstraZeneca chief executive, Pascal Soriot, said his team of researchers are almost sure that the Oxford vaccine will be able to fight against the novel coronavirus. The British-Swedish pharma giant AstraZeneca has partnered with the University of Oxford and Pune-based SII for the rollout of their Covid-19 vaccine. Also read Our vaccine can be effective against new coronavirus variant: AstraZenecaPascal Soriot told British daily the Sunday Times that Oxford's Covid-19 vaccine is "as effective as the Pfizer and Moderna" alternatives. On Saturday, sources told news agency PTI that the DCGI (Drug Controller General of India) was waiting for the British drug regulator to clear the Oxford vaccine.


Source: dna December 28, 2020 02:15 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */